Risk evaluation of carbapenem-induced liver injury based on machine learning analysis
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Pharmacology (medical),Microbiology (medical)
Reference32 articles.
1. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy;Tujios;Liver Int,2018
2. Drug-induced liver injury;Katarey;Clin Med,2016
3. Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
4. Antibacterial Resistance Leadership Group. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia;Tamma;Clin Infect Dis,2015
5. Signal detection of potentially drug-induced liver injury in children using electronic Health records;Yu;Front Pediatr,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interpretable multitemporal liver function indicator model for prediction and risk factor analysis of drug induced liver injury;Scientific Reports;2024-09-12
2. A decision tree model for predicting high mono-N-desethylamiodarone concentrations and reducing tissue toxicity in patients with low-dose amiodarone therapy: A multicentral retrospective cohort study;Int. Journal of Clinical Pharmacology and Therapeutics;2024-09-01
3. Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study;Annals of Pharmacotherapy;2024-06-05
4. Future Perspectives on Radiomics in Acute Liver Injury and Liver Trauma;Journal of Personalized Medicine;2024-05-27
5. Effect of Ceftriaxone Dosage and Albumin–Bilirubin Score on the Risk of Ceftriaxone-Induced Liver Injury;Biological and Pharmaceutical Bulletin;2023-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3